Zucker diabetic fatty (ZDF) rats, an animal model of human type 2 diabetes, have a blunted response to hyperglycemia with a failure to suppress net hepatic glucose production and increase glucose flux to glycogen, which are associated with a failure to stimulate glucose phosphorylation catalyzed by glucokinase (GK). We found impairments in GK regulation occur during the progression of diabetes in ZDF rats. During an early stage of diabetes (~10 weeks of age), characterized by excessive postprandial hyperglycemia and hyperinsulinemia, GK resides with its inhibitory protein (GKRP) in the nucleus and fails to translocate to the cytoplasm where its activity would normally promote glucose phosphorylation. During a middle stage of diabetes (~14 weeks of age), characterized by prolonged and marked hyperglycemia and hyperinsulinemia, glucose phosphorylation is impaired despite a continuous residency in the cytoplasm of GK. During a late stage of diabetes (~20 weeks of age), characterized by prolonged and extreme hyperglycemia and euinsulin- emia, GK expression was markedly decreased. Additionally, preventing large excursions of postprandial and prolonged postabsorptive hyperglycemia reversed the GK impairments observed in ZDF rats. To explore the mechanisms responsible for each type of altered GK regulation, we propose three aims. First, we propose to examine why GK fails to translocate from the nucleus to the cytoplasm in response to a rise in plasma glucose in 10-week old ZDF rats. We will assess whether the colocalization of GK and GKRP in the nucleus after a rise in glucose concentration is due to a failure of GK to dissociate from GKRP or to be retained in the cytoplasm. Second, we will determine how chronically increased postprandial hyperglycemia impairs GK translocation from the nucleus to the cytoplasm in response to a postprandial signal of hyperglycemia and hyperinsulinemia in 10-week old ZDF rats. We will address whether the ability of insulin to facilitate glucose action and/or the ability of glucose per se to signal hepatic GK translocation is impaired and whether GK translocation is prevented by the inability of GK to bind to a cytoplasmic protein partner, 6-phosphofructose-2- kinase/fructose-2,6-phosphatase. Thirdly, we will examine why chronic hyperglycemia decreases GK expression in 14 to 18 week old ZDF rats. We will assess whether chronic hyperglycemia decreases GK expression by directly affecting the liver or by decreasing insulin secretion, and whether maintaining GK expression by preventing hyperglycemia is associated with maintaining GK gene transcription or improved stability of GK protein. To execute these aims we will use isolated hepatocytes for Aim 1 and isotopic and chronic catheterization techniques to perform glucose and pancreatic clamps in conscious ZDF rats in Aim 2 and 3. Chronic hyperglycemia will be altered by a phlorizin analogue. These experiments directed towards understanding the mechanism by which chronic hyperglycemia impairs the action of glucose and/or insulin on the liver will provide the basis for improved management and therapeutic treatment of type 2 diabetes.

Public Health Relevance

The liver is an important organ for the maintenance of normal blood glucose and an impairment of the liver to switch from a producer to a consumer of glucose contributes to the elevated blood glucose associated with many of the complications of type 2 diabetes. We found that inappropriate regulation within the liver of a key metabolic enzyme, glucokinase, is caused by elevated blood glucose, which can lead to a further elevation of blood glucose. We propose to determine in a diabetic animal model of type 2 diabetes the reasons for impaired glucokinase activity, and mechanism by which improved glycemic control reverses this impairment and the potential for diabetic complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK060667-07
Application #
7640628
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Laughlin, Maren R
Project Start
2002-02-20
Project End
2012-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
7
Fiscal Year
2009
Total Cost
$321,599
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Syring, Kristen E; Bosma, Karin J; Oeser, James K et al. (2018) The Diabetes Susceptibility Gene SLC30A8 that Encodes the Zinc Transporter ZnT8 is a Pseudogene in Guinea Pigs Potentially Contributing to Low Guinea Pig Islet Zinc Content. J Mol Evol 86:613-617
O'Brien, Tracy P; Jenkins, Erin C; Estes, Shanea K et al. (2017) Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle. Diabetes 66:1172-1184
Leamy, Alexandra K; Hasenour, Clinton M; Egnatchik, Robert A et al. (2016) Knockdown of triglyceride synthesis does not enhance palmitate lipotoxicity or prevent oleate-mediated rescue in rat hepatocytes. Biochim Biophys Acta 1861:1005-1014
Farmer, Tiffany D; Jenkins, Erin C; O'Brien, Tracy P et al. (2015) Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp. Am J Physiol Endocrinol Metab 308:E206-22
Leamy, Alexandra K; Egnatchik, Robert A; Shiota, Masakazu et al. (2014) Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J Lipid Res 55:1478-88
Ueta, Kiichiro; O'Brien, Tracy P; McCoy, Gregory A et al. (2014) Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity. Am J Physiol Endocrinol Metab 306:E1225-38
Pound, Lynley D; Oeser, James K; O'Brien, Tracy P et al. (2013) G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes 62:1547-56
Torres, Tracy P; Fujimoto, Yuka; Donahue, E P et al. (2011) Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats. Diabetes 60:2225-33
Torres, Tracy P; Catlin, Reetta L; Chan, Robert et al. (2009) Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats. Diabetes 58:78-86
Fujimoto, Yuka; Torres, Tracy P; Donahue, E Patrick et al. (2006) Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 55:2479-90

Showing the most recent 10 out of 12 publications